Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 2
1967 2
1968 2
1969 2
1970 3
1971 5
1972 5
1973 9
1974 6
1975 6
1976 9
1977 4
1978 5
1979 5
1980 11
1981 15
1982 9
1983 7
1984 15
1985 23
1986 14
1987 14
1988 22
1989 23
1990 41
1991 39
1992 48
1993 32
1994 44
1995 42
1996 53
1997 41
1998 58
1999 37
2000 40
2001 55
2002 50
2003 67
2004 89
2005 56
2006 66
2007 69
2008 67
2009 76
2010 80
2011 84
2012 105
2013 110
2014 110
2015 132
2016 123
2017 129
2018 92
2019 129
2020 185
2021 205
2022 158
2023 173
2024 76

Text availability

Article attribute

Article type

Publication date

Search Results

2,874 results

Results by year

Filters applied: . Clear all
Page 1
Interstitial lung disease.
Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Poletti V. Antoniou KM, et al. Eur Respir Rev. 2014 Mar 1;23(131):40-54. doi: 10.1183/09059180.00009113. Eur Respir Rev. 2014. PMID: 24591661 Free PMC article. Review.
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidity and mortality. ...Early diagnosis and disease stratification is also important in the field of other interstitial lung
Interstitial lung diseases are a group of diffuse parenchymal lung disorders associated with substantial morbidi
Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis.
Wu W, Guo L, Fu Y, Wang K, Zhang D, Xu W, Chen Z, Ye S. Wu W, et al. Clin Rev Allergy Immunol. 2021 Apr;60(2):293-304. doi: 10.1007/s12016-020-08822-5. Epub 2021 Jan 6. Clin Rev Allergy Immunol. 2021. PMID: 33405101 Review.
Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5(+) DM) is a rare autoimmune disease predominantly reported in East Asia. MDA5(+) DM is an intractable disease with impressively high mortality due to rapid-progressive interstitial
Anti-melanoma differentiation-associated gene 5-positive dermatomyositis (MDA5(+) DM) is a rare autoimmune disease predominantly repo …
Dermatomyositis: Clinical features and pathogenesis.
DeWane ME, Waldman R, Lu J. DeWane ME, et al. J Am Acad Dermatol. 2020 Feb;82(2):267-281. doi: 10.1016/j.jaad.2019.06.1309. Epub 2019 Jul 4. J Am Acad Dermatol. 2020. PMID: 31279808 Review.
Dermatomyositis: Diagnosis and treatment.
Waldman R, DeWane ME, Lu J. Waldman R, et al. J Am Acad Dermatol. 2020 Feb;82(2):283-296. doi: 10.1016/j.jaad.2019.05.105. Epub 2019 Jul 4. J Am Acad Dermatol. 2020. PMID: 31279813 Review.
The second article in this continuing medical education series reviews the initial evaluation of patients with suspected dermatomyositis (DM), the relevant work-up for malignancy and interstitial lung disease once a diagnosis of DM is made, and treatment reco …
The second article in this continuing medical education series reviews the initial evaluation of patients with suspected dermatomyositis (DM …
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment.
Conte P, Ascierto PA, Patelli G, Danesi R, Vanzulli A, Sandomenico F, Tarsia P, Cattelan A, Comes A, De Laurentiis M, Falcone A, Regge D, Richeldi L, Siena S. Conte P, et al. ESMO Open. 2022 Apr;7(2):100404. doi: 10.1016/j.esmoop.2022.100404. Epub 2022 Feb 24. ESMO Open. 2022. PMID: 35219244 Free PMC article. Review.
BACKGROUND: Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung disease resulting from exposure to drugs causing inflammation and possibly interstitial fibrosis. ...Important components of the diagnostic p …
BACKGROUND: Drug-induced interstitial lung disease (DIILD) is a form of interstitial lung disease
Interstitial Lung Disease: A Review.
Maher TM. Maher TM. JAMA. 2024 May 21;331(19):1655-1665. doi: 10.1001/jama.2024.3669. JAMA. 2024. PMID: 38648021 Review.
IMPORTANCE: Interstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation and/or fibrosis of the lung parenchyma associated with progressive dyspnea that frequently results in end-stage respiratory failure. .. …
IMPORTANCE: Interstitial lung disease (ILD) consists of a group of pulmonary disorders characterized by inflammation an …
Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review.
Tarantino P, Modi S, Tolaney SM, Cortés J, Hamilton EP, Kim SB, Toi M, Andrè F, Curigliano G. Tarantino P, et al. JAMA Oncol. 2021 Dec 1;7(12):1873-1881. doi: 10.1001/jamaoncol.2021.3595. JAMA Oncol. 2021. PMID: 34647966 Review.
Despite an improved overall therapeutic index, clinical observations have recently raised a concern regarding potential lung toxicity of anti-ERBB2 ADCs. Deaths related to interstitial lung disease (ILD) have been reported with variable incidence in tr …
Despite an improved overall therapeutic index, clinical observations have recently raised a concern regarding potential lung toxicity …
Interstitial Pneumonia with Autoimmune Features.
Graney BA, Fischer A. Graney BA, et al. Ann Am Thorac Soc. 2019 May;16(5):525-533. doi: 10.1513/AnnalsATS.201808-565CME. Ann Am Thorac Soc. 2019. PMID: 30695649 Free PMC article. Review.
Interstitial pneumonia with autoimmune features (IPAF) is a research classification proposed by the European Respiratory Society/American Thoracic Society Task Force on Undifferentiated Forms of Connective Tissue Disease-associated Interstitial Lung
Interstitial pneumonia with autoimmune features (IPAF) is a research classification proposed by the European Respiratory Society/Amer
Mechanisms of progressive fibrosis in connective tissue disease (CTD)-associated interstitial lung diseases (ILDs).
Spagnolo P, Distler O, Ryerson CJ, Tzouvelekis A, Lee JS, Bonella F, Bouros D, Hoffmann-Vold AM, Crestani B, Matteson EL. Spagnolo P, et al. Ann Rheum Dis. 2021 Feb;80(2):143-150. doi: 10.1136/annrheumdis-2020-217230. Epub 2020 Oct 9. Ann Rheum Dis. 2021. PMID: 33037004 Free PMC article. Review.
Interstitial lung diseases (ILDs), which can arise from a broad spectrum of distinct aetiologies, can manifest as a pulmonary complication of an underlying autoimmune and connective tissue disease (CTD-ILD), such as rheumatoid arthritis-ILD and systemi
Interstitial lung diseases (ILDs), which can arise from a broad spectrum of distinct aetiologies, can manifest as a pul
Acute exacerbation of interstitial lung disease associated with rheumatic disease.
Luppi F, Sebastiani M, Salvarani C, Bendstrup E, Manfredi A. Luppi F, et al. Nat Rev Rheumatol. 2022 Feb;18(2):85-96. doi: 10.1038/s41584-021-00721-z. Epub 2021 Dec 7. Nat Rev Rheumatol. 2022. PMID: 34876670 Review.
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic diseases, such as connective-tissue diseases, rheumatoid arthritis and systemic vasculitis. Some patients with ILD secondary to rheumatic disease
Interstitial lung disease (ILD) is a cause of morbidity and mortality in patients with rheumatic diseases, such
2,874 results